SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,820 | -68.6% | 66 | -50.0% | 0.00% | – |
| Q2 2023 | $5,792 | +52.1% | 132 | +100.0% | 0.00% | – |
| Q1 2023 | $3,808 | +2325.5% | 66 | -97.7% | 0.00% | -100.0% |
| Q4 2022 | $157 | -99.9% | 2,809 | -3.9% | 0.00% | 0.0% |
| Q3 2022 | $164,000 | +17.1% | 2,923 | +17.7% | 0.00% | 0.0% |
| Q2 2022 | $140,000 | -27.5% | 2,483 | -27.4% | 0.00% | +100.0% |
| Q1 2022 | $193,000 | +565.5% | 3,422 | +270.7% | 0.00% | +100.0% |
| Q4 2021 | $29,000 | +3.6% | 923 | -2.4% | 0.00% | 0.0% |
| Q3 2021 | $28,000 | +366.7% | 946 | +414.1% | 0.00% | – |
| Q2 2021 | $6,000 | +200.0% | 184 | +178.8% | 0.00% | – |
| Q1 2021 | $2,000 | – | 66 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $57,000 | -35.2% | 1,759 | +1.2% | 0.00% | -25.0% |
| Q3 2018 | $88,000 | -41.7% | 1,738 | -31.1% | 0.00% | -33.3% |
| Q2 2018 | $151,000 | +81.9% | 2,523 | +20.9% | 0.01% | +50.0% |
| Q1 2018 | $83,000 | 0.0% | 2,086 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $83,000 | -30.8% | 2,086 | -30.7% | 0.00% | -20.0% |
| Q3 2017 | $120,000 | +11.1% | 3,011 | +20.2% | 0.01% | 0.0% |
| Q2 2017 | $108,000 | +35.0% | 2,504 | -1.7% | 0.01% | +66.7% |
| Q1 2017 | $80,000 | +37.9% | 2,547 | +10.5% | 0.00% | 0.0% |
| Q4 2016 | $58,000 | -1.7% | 2,305 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $59,000 | +20.4% | 2,373 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $49,000 | +81.5% | 2,413 | +19.2% | 0.00% | +50.0% |
| Q4 2015 | $27,000 | – | 2,025 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |